In the PROGRESS-AMS trial, Erbel and colleagues assessed the feasibility of bioabsorbable coronary stents made from a magnesium alloy—demonstrated in animal pilot studies to be completely ...

The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

"BD treats first subject in trial of bioabsorbable scaffold" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been ...

FRANKLIN LAKES, N.J., March 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...